Atlas Capital Advisors’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-425
| Closed | -$4.04K | – | 897 |
|
|
2022
Q3 | $4.04K | Buy |
+425
| New | +$4.04K | ﹤0.01% | 790 |
|
|
2022
Q2 | – | Sell |
-425
| Closed | -$5.57K | – | 972 |
|
|
2022
Q1 | $5.57K | Hold |
425
| – | – | ﹤0.01% | 783 |
|
|
2021
Q4 | $7.48K | Hold |
425
| – | – | ﹤0.01% | 754 |
|
|
2021
Q3 | $9.22K | Hold |
425
| – | – | ﹤0.01% | 735 |
|
|
2021
Q2 | $14.9K | Hold |
425
| – | – | ﹤0.01% | 684 |
|
|
2021
Q1 | $41.9K | Sell |
425
-220
| -34% | -$21.7K | 0.01% | 509 |
|
|
2020
Q4 | $69.9K | Buy |
+645
| New | +$69.9K | 0.01% | 439 |
|
|
2020
Q3 | – | Sell |
-20
| Closed | -$4.18K | – | 313 |
|
|
2020
Q2 | $4.18K | Sell |
20
-272
| -93% | -$56.8K | ﹤0.01% | 644 |
|
|
2020
Q1 | $28.5K | Buy |
+292
| New | +$28.5K | 0.01% | 487 |
|